Alpha-Fetoprotein Antigen (AFP), Recombinant
Alpha-Fetoprotein Antigen (AFP), Recombinant | Cat# A1006
Product Description:
Recombinant Alpha-Fetoprotein (AFP) – Cat# A1006 – is a high-purity tumor marker antigen produced through advanced recombinant expression systems. AFP is a fetal glycoprotein typically produced by the liver and yolk sac, widely used as a biomarker in hepatocellular carcinoma, germ cell tumors, and fetal development studies. This recombinant form offers superior consistency and purity, making it ideal for use in immunoassays, diagnostic kit manufacturing, and cancer biomarker research.
Key Features:
Recombinant form ensures high consistency and purity
Ideal for ELISA, western blotting, and tumor marker assays
Suitable for oncology, hepatology, and prenatal research applications
Applications:
Development and calibration of AFP immunoassays
Diagnostic quality controls for cancer screening
Research in liver cancer and fetal health biomarkers
Alpha-Fetoprotein Antigen (AFP), Recombinant | Cat# A1006
Product Description:
Recombinant Alpha-Fetoprotein (AFP) – Cat# A1006 – is a high-purity tumor marker antigen produced through advanced recombinant expression systems. AFP is a fetal glycoprotein typically produced by the liver and yolk sac, widely used as a biomarker in hepatocellular carcinoma, germ cell tumors, and fetal development studies. This recombinant form offers superior consistency and purity, making it ideal for use in immunoassays, diagnostic kit manufacturing, and cancer biomarker research.
Key Features:
Recombinant form ensures high consistency and purity
Ideal for ELISA, western blotting, and tumor marker assays
Suitable for oncology, hepatology, and prenatal research applications
Applications:
Development and calibration of AFP immunoassays
Diagnostic quality controls for cancer screening
Research in liver cancer and fetal health biomarkers
Alpha-Fetoprotein Antigen (AFP), Recombinant | Cat# A1006
Product Description:
Recombinant Alpha-Fetoprotein (AFP) – Cat# A1006 – is a high-purity tumor marker antigen produced through advanced recombinant expression systems. AFP is a fetal glycoprotein typically produced by the liver and yolk sac, widely used as a biomarker in hepatocellular carcinoma, germ cell tumors, and fetal development studies. This recombinant form offers superior consistency and purity, making it ideal for use in immunoassays, diagnostic kit manufacturing, and cancer biomarker research.
Key Features:
Recombinant form ensures high consistency and purity
Ideal for ELISA, western blotting, and tumor marker assays
Suitable for oncology, hepatology, and prenatal research applications
Applications:
Development and calibration of AFP immunoassays
Diagnostic quality controls for cancer screening
Research in liver cancer and fetal health biomarkers
Testing:
This material has been tested for HIV 1/2, HIV-1 (NAT), HBsAg, HBV (NAT), HCV, HCV (NAT), and RPR by FDA approved methods and found to be NON-REACTIVE.
Intended Use and Customer Responsibility
Golden West BioSolutions, LLC products are specifically designed for research and the manufacturing of non-injectable products. It is the customer's responsibility to handle these products safely and responsibly. Golden West BioSolutions, LLC is not liable for any injuries stemming from the use or handling of its products. All disposal procedures must align with federal and state regulations.
Quality Assurance Disclaimer
Golden West BioSolutions, LLC does not warrant the performance of their products in specific applications. Customers are responsible for determining the suitability and qualification of Golden West BioSolution products for their intended use. Given the natural variation in biological materials, Golden West BioSolutions, LLC also recommends consideration of lot-to-lot evaluation.